"Treatment Outcome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.
| Descriptor ID |
D016896
|
| MeSH Number(s) |
E01.789.800 N04.761.559.590.800 N05.715.360.575.575.800
|
| Concept/Terms |
Clinical Effectiveness- Clinical Effectiveness
- Clinical Effectivenesses
- Effectiveness, Clinical
- Effectivenesses, Clinical
- Patient-Relevant Outcome
- Outcome, Patient-Relevant
- Outcomes, Patient-Relevant
- Patient Relevant Outcome
- Patient-Relevant Outcomes
- Clinical Efficacy
- Efficacy, Clinical
|
Below are MeSH descriptors whose meaning is more general than "Treatment Outcome".
Below are MeSH descriptors whose meaning is more specific than "Treatment Outcome".
This graph shows the total number of publications written about "Treatment Outcome" by people in this website by year, and whether "Treatment Outcome" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 29 | 29 |
| 1995 | 0 | 34 | 34 |
| 1996 | 0 | 53 | 53 |
| 1997 | 1 | 62 | 63 |
| 1998 | 1 | 76 | 77 |
| 1999 | 1 | 65 | 66 |
| 2000 | 0 | 87 | 87 |
| 2001 | 0 | 115 | 115 |
| 2002 | 0 | 104 | 104 |
| 2003 | 2 | 134 | 136 |
| 2004 | 0 | 153 | 153 |
| 2005 | 3 | 171 | 174 |
| 2006 | 1 | 180 | 181 |
| 2007 | 0 | 232 | 232 |
| 2008 | 1 | 219 | 220 |
| 2009 | 4 | 251 | 255 |
| 2010 | 0 | 276 | 276 |
| 2011 | 1 | 315 | 316 |
| 2012 | 2 | 279 | 281 |
| 2013 | 3 | 292 | 295 |
| 2014 | 0 | 286 | 286 |
| 2015 | 1 | 270 | 271 |
| 2016 | 2 | 302 | 304 |
| 2017 | 2 | 290 | 292 |
| 2018 | 2 | 308 | 310 |
| 2019 | 0 | 331 | 331 |
| 2020 | 2 | 292 | 294 |
| 2021 | 0 | 253 | 253 |
| 2022 | 0 | 203 | 203 |
| 2023 | 0 | 208 | 208 |
| 2024 | 0 | 163 | 163 |
To return to the timeline,
click here.
Below are the most recent publications written about "Treatment Outcome" by people in Profiles.
-
Increased apathy post-interstitial laser capsulotomy for refractory obsessive-compulsive disorder. J Neurol Neurosurg Psychiatry. 2024 Sep 17; 95(10):899-901.
-
Does stereotactic thrombolysis with alteplase for intracerebral haemorrhage alter intraventricular haematoma volume? A secondary analysis of the MISTIE-III trial. J Neurol Neurosurg Psychiatry. 2024 Sep 17; 95(10):892-898.
-
Atezolizumab Before and After Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer: A Phase II Nonrandomized Controlled Trial. JAMA Oncol. 2024 Sep 01; 10(9):1212-1219.
-
MRI Predicts Residual Disease and Outcomes in Watch-and-Wait Patients with Rectal Cancer. Radiology. 2024 09; 312(3):e232748.
-
The #HOPE4LIVER Single-Arm Pivotal Trial for Histotripsy of Primary and Metastatic Liver Tumors. Radiology. 2024 09; 312(3):e233051.
-
Robotic totally endoscopic aortic valve replacement with a sutured bioprosthesis. Multimed Man Cardiothorac Surg. 2024 Aug 29; 2024.
-
Cerebral small vessel disease modifies outcomes after minimally invasive surgery for intracerebral haemorrhage. Stroke Vasc Neurol. 2024 Aug 27; 9(4):446-456.
-
Belzutifan versus Everolimus for Advanced Renal-Cell Carcinoma. N Engl J Med. 2024 Aug 22; 391(8):710-721.
-
Real-world use of tisagenlecleucel in children and young adults with relapsed or refractory B-cell lymphomas. Blood Adv. 2024 Aug 13; 8(15):4164-4168.
-
Impact of aspirin dose according to race in secondary prevention of atherosclerotic cardiovascular disease: a secondary analysis of the ADAPTABLE randomised controlled trial. BMJ Open. 2024 Aug 07; 14(8):e078197.